tiprankstipranks
Bio-Rad Laboratories (BIO)
NYSE:BIO
Holding BIO?
Track your performance easily

Bio-Rad Laboratories (BIO) Financial Statements

863 Followers

Bio-Rad Laboratories Financial Overview

Bio-Rad Laboratories's market cap is currently ―. The company's EPS TTM is $-27.333; its P/E ratio is -11.98; Bio-Rad Laboratories is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $2.87. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 649.70M$ 638.50M$ 610.82M$ 681.18M$ 632.10M
Gross Profit$ 355.90M$ 355.12M$ 325.97M$ 366.36M$ 335.68M
EBIT$ 873.79M$ -2.77B$ 503.36M$ 440.75M$ 149.50M
EBITDA$ 912.69M$ -2.77B$ 540.46M$ 477.95M$ 149.50M
Net Income Common Stockholders$ 653.17M$ -2.17B$ 383.92M$ 349.71M$ 106.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.62B$ 1.62B$ 1.65B$ 1.61B$ 1.76B
Total Assets$ 10.60B$ 9.69B$ 12.61B$ 12.30B$ 11.90B
Total Debt$ 1.39B$ 1.39B$ 1.40B$ 1.41B$ 1.41B
Net Debt$ -234.38M$ -223.41M$ -245.95M$ -201.75M$ -353.51M
Total Liabilities$ 3.12B$ 2.91B$ 3.56B$ 3.56B$ 3.48B
Stockholders Equity$ 7.49B$ 6.78B$ 9.05B$ 8.74B$ 8.42B
Cash Flow-
Free Cash Flow$ 123.44M$ 55.43M$ 29.64M$ 38.80M$ 53.70M
Operating Cash Flow$ 163.61M$ 97.65M$ 69.79M$ 81.05M$ 97.71M
Investing Cash Flow$ -55.64M$ -30.93M$ -43.09M$ 72.20M$ -9.50M
Financing Cash Flow$ -95.99M$ -96.59M$ 21.00K$ -200.62M$ -26.60M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

Bio-Rad Laboratories Debt to Assets

Bio-Rad Laboratories Cash Flow

Bio-Rad Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis